¹Ì±¹ÀÇ ºñ¸¸ ÀÎÅͺ¥¼Ç ½ÃÀå : Medtech 360
Obesity Interventions | Medtech 360 | Market Insights | United States
»óǰÄÚµå : 1745940
¸®¼­Ä¡»ç : Clarivate
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 10,388 £Ü 14,447,000
Web Access and PDF Download (Corporate Use License) help
µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½º ÀÔ´Ï´Ù. À̸ÞÀÏ·Î ¸µÅ©¿Í ºñ¹Ð¹øÈ£¸¦ º¸³» µå¸³´Ï´Ù. ÀÎÅÍ³Ý ¿¬°á·Î ¿­¶÷ÀÌ °¡´ÉÇϰí PDF º¸°í¼­ ´Ù¿î·Îµå°¡ °¡´ÉÇÕ´Ï´Ù. ÀμⰡ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â PDF ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

GLP-1 ¼ö¿ëü ÀÛ¿ëÁ¦ÀÇ ´ëµÎ´Â ºñ¸¸ ÀÎÅͺ¥¼ÇÀÇ Á¤¼¼¸¦ Å©°Ô ¹Ù²ã ºñ¸¸ ÀÎÅͺ¥¼ÇÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ÁÖ°í ±â±âÀÇ ¸ÅÃâ¿¡µµ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. GLP-1 ºÐ¾ß¿¡¼­ÀÇ ±â¼ú Çõ½Å°ú ¹Ì·¡ »óȯÀº ºñ¸¸ ÀÎÅͺ¥¼Ç ¼ö¿ä¿¡ Áö¼ÓÀûÀ¸·Î ÇÏ¹æ ¾Ð·ÂÀ» °¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ »óȲ¿¡µµ ºÒ±¸ÇÏ°í ºñ¸¸Àα¸ÀÇ È®´ë ¹× Ä¡·áÀ² Áõ°¡°¡ ºñ¸¸ ÀÎÅͺ¥¼Ç ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³ª¾Æ°¡ ´õ ħ½À¼ºÀÌ ³·Àº ³»°­ Ä¡·á¿Í ´õ ³ôÀº °¡°ÝÀ» ¿ä±¸ÇÏ´Â Çõ½ÅÀû ±â¼úÀÇ Ã¤ÅÃÀÌ ºñ¸¸ ÀÎÅͺ¥¼Ç ½ÃÀå À¯Áö¿¡ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

GLP-1 ¼ö¿ëü ÀÛ¿ëÁ¦´Â ÃÖ±Ù ¹Ì±¹ ȯÀÚ Áý´Üµé »çÀÌ¿¡¼­ ä¿ëÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.

·Îº¿ Áö¿ø ºñ¸¸ ÀÎÅͺ¥¼ÇÀÌ ºñ¸¸ ÀÎÅͺ¥¼Ç ½ÃÀå Àüü¸¦ Áö¿øÇÕ´Ï´Ù.

¹Ì±¹ ÀÇ»çµé »çÀÌ¿¡¼­ üÁß °¨·®À» À§ÇØ »õ·Î¿î ºñ¸¸ ÀÎÅͺ¥¼ÇÀ» äÅÃÇÏ´Â µ¿ÇâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£¿¡ »õ·Î¿î °æÀïÀÌ ÀÌ ºÐ¾ß¿¡ ÁøÀÔÇÒ Àü¸ÁÀÔ´Ï´Ù.

ÀÌ º¸°í¼­´Â ¹Ì±¹ÀÇ ºñ¸¸ ÀÎÅͺ¥¼Ç ½ÃÀå¿¡ ´ëÇÑ Á¶»ç ºÐ¼®À» ÅëÇØ 2019-2034³â ½ÃÀå »óȲ¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ µ¥ÀÌÅÍ¿Í ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

¹Ì±¹

¿ä¾à

ÁÖ¿ä ¿ä¾à

ÁÖ¿ä º¸°í¼­ ¾÷µ¥ÀÌÆ®

ºñ¸¸ ÀÎÅͺ¥¼Ç ½ÃÀå

À§ ¹êµå ½ÃÀå

³»ºÎ Æó¼â Àåºñ ½ÃÀå

À§³» dz¼± ½ÃÀå

ºÎ·Ï

Á¶»ç ¹æ¹ý

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The rise of GLP-1 receptor agonists is significantly transforming the landscape of obesity treatment, impacting the growth of bariatric procedures and affecting device sales. Innovations and future reimbursements in the GLP-1 space are expected to continue placing downward pressure on the demand for bariatric procedures. Despite this, the growing obese population and increased treatment rates are anticipated to drive the obesity intervention market. Additionally, less-invasive endoluminal procedures and the adoption of innovative technologies that command higher prices will contribute to sustaining the obesity intervention market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the obesity intervention market in the US from 2019 through 2034.

GLP-1 receptor agonists have been experiencing a meteoric rise in adoption among the US patient population in recent years.

Robotic-assisted bariatric procedures will support the overall obesity intervention market.

There is a growing trend among US physicians to adopt novel bariatric procedures for weight loss.

New competitors are expected to enter this space within the forecast period.

Table of Contents

United States

Abstract

Executive Summary

Key Report Updates

Obesity Intervention Market

Gastric Band Market

Internal Closure Device Market

Intragastric Balloon Market

Appendix

Methodology

Tables and figures

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â